{"id":109688,"date":"2021-03-16T16:19:18","date_gmt":"2021-03-16T16:19:18","guid":{"rendered":"https:\/\/fin2me.com\/?p=109688"},"modified":"2021-03-16T16:19:18","modified_gmt":"2021-03-16T16:19:18","slug":"pfizer-to-deliver-200-million-vaccine-doses-to-eu-in-second-quarter","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/pfizer-to-deliver-200-million-vaccine-doses-to-eu-in-second-quarter\/","title":{"rendered":"Pfizer to deliver 200 million vaccine doses to EU in second quarter"},"content":{"rendered":"
BRUSSELS (Reuters) – The European Commission expects to receive about 200 million doses of the Pfizer\/BioNTech COVID-19 vaccine in the second quarter, it said for the first time on Tuesday.<\/p> The EU is aiming to vaccinate at least 255 million people, or 70% of its adult population, by the end of the summer but has faced criticism for the slow rollout of its inoculation drive.<\/p>\n Besides supply delays from some drugmakers and hiccups in vaccination plans, the suspension of inoculations using the AstraZeneca vaccine due to potential health issues is also affecting the bloc\u2019s campaign.<\/p>\n The EU had not previously said how many doses of the Pfizer\/BioNTech vaccine, which is administered in two shots, it would receive in the April-June period under two confidential supply contracts with the drugmakers.<\/p>\n The expected Pfizer second-quarter deliveries will include 10 million doses originally due in the third and fourth quarters of this year, the Commission said.<\/p>\n The announcement does not change the EU\u2019s overall forecast for vaccine supplies of 300 million doses in the second quarter from all the drugmakers the bloc has signed contracts with.<\/p>\n \u201cThese accelerated 10 million doses will bring the total doses of BioNTech\/Pfizer in quarter two up to over 200 million,\u201d Commission President Ursula von der Leyen said.<\/p>\n \u201cThis is very good news. It gives member states room to manoeuvre and possibly fill gaps in deliveries,\u201d she said.<\/p>\n Pfizer confirmed the EU statement regarding its second-quarter supply.<\/p>\n The additional 10 million doses would be moved forward from an option for 100 million doses in a second contract the EU signed with the drugmakers in January, the EU statement said.<\/p>\n In total, the EU has booked 600 million doses from the two companies in the two contracts.<\/p>\n A Commission spokesman told a news conference that the announcement would not lead at this point to a revision of the EU\u2019s overall second-quarter delivery forecasts, even though the total announced and expected deliveries was now higher.<\/p>\n The spokesman said delivery schedules could always change so forecasts were not always updated after announcements.<\/p>\n The EU expects to get 55 million vaccine doses from Johnson & Johnson and 35 million from Moderna in the second quarter, according to a delivery schedule published by the Italian government and an internal document on supply forecasts from Germany\u2019s health ministry.<\/p>\n AstraZeneca last week announced that it aimed to deliver 70 million doses to the 27-nation bloc in the second quarter, well below its original contractual obligation of 180 million.<\/p>\n In the first three months of the year, the EU expects to receive about 100 million doses from Pfizer, AstraZeneca and Moderna.<\/p>\n (The story refiles to fix typo in headline.)<\/p>\n